(Q44519250)

English

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC). (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

brain metastasis

1 reference

based on heuristic

inferred from title

Federico Cappuzzo

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

object named as

Marcello Tiseo

6

0 references

Cesare Gridelli

4

object named as

Cesare Gridelli

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Andrea Ardizzoni

2

object named as

Andrea Ardizzoni

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Hector Soto-Parra

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Paolo Maione

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Cesare Calandri

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Stefania Bartolini

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Armando Santoro

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Lucio Crinò

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

227-231

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900189-2

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900189-2

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900189-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900189-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(03)00189-2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44519250&oldid=1768034701"